161 related articles for article (PubMed ID: 24033905)
1. Automatic oral fluid-based HIV testing in HIV screening programmes: automatic for the people.
Rayment M; Doku E; Thornton A; Pearn M; Sudhanva M; Jones R; Nardone A; Roberts P; Tenant-Flowers M; Anderson J; Sullivan AK; Atkins M
HIV Med; 2013 Oct; 14 Suppl 3():49-52. PubMed ID: 24033905
[TBL] [Abstract][Full Text] [Related]
2. Pilot of non-invasive (oral fluid) testing for HIV within a clinical setting.
Debattista J; Bryson G; Roudenko N; Dwyer J; Kelly M; Hogan P; Patten J
Sex Health; 2007 Jun; 4(2):105-9. PubMed ID: 17524288
[TBL] [Abstract][Full Text] [Related]
3. Using conventional HIV tests on oral fluid.
Fransen K; Vermoesen T; Beelaert G; Menten J; Hutse V; Wouters K; Platteau T; Florence E
J Virol Methods; 2013 Dec; 194(1-2):46-51. PubMed ID: 23969313
[TBL] [Abstract][Full Text] [Related]
4. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
Wesolowski LG; MacKellar DA; Facente SN; Dowling T; Ethridge SF; Zhu JH; Sullivan PS;
AIDS; 2006 Aug; 20(12):1661-6. PubMed ID: 16868448
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Calypte AWARE HIV-1/2 OMT antibody test as a screening test in an Indian setting.
Ingole NA; Mehta PR; Bande RN; Paranjpe SM; Wanjare SW
Indian J Med Microbiol; 2010; 28(4):295-8. PubMed ID: 20966557
[TBL] [Abstract][Full Text] [Related]
6. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples.
Malm K; von Sydow M; Andersson S
Transfus Med; 2009 Apr; 19(2):78-88. PubMed ID: 19320855
[TBL] [Abstract][Full Text] [Related]
7. Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: special challenges of rapid HIV testing in the developing world.
Gottfried TD; Mink RW; Phanuphak P
Expert Rev Mol Diagn; 2006 Mar; 6(2):139-44. PubMed ID: 16512774
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India.
Pant Pai N; Joshi R; Dogra S; Taksande B; Kalantri SP; Pai M; Narang P; Tulsky JP; Reingold AL
PLoS One; 2007 Apr; 2(4):e367. PubMed ID: 17426815
[TBL] [Abstract][Full Text] [Related]
9. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies.
Delaney KP; Branson BM; Uniyal A; Kerndt PR; Keenan PA; Jafa K; Gardner AD; Jamieson DJ; Bulterys M
AIDS; 2006 Aug; 20(12):1655-60. PubMed ID: 16868447
[TBL] [Abstract][Full Text] [Related]
10. Pilot of non-invasive (oral fluid) testing for HIV within a community setting.
Birrell F; Staunton S; Debattista J; Roudenko N; Rutkin W; Davis C
Sex Health; 2010 Mar; 7(1):11-6. PubMed ID: 20152090
[TBL] [Abstract][Full Text] [Related]
11. False-positive oral fluid rapid HIV tests--New York City, 2005-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(24):660-5. PubMed ID: 18566566
[TBL] [Abstract][Full Text] [Related]
12. [Oral fluid and urine as alternative samples in confirmatory testing of HIV-1 infection].
Cruz Sui O; Pérez Guevara MT; Lubián Caballero AL; Montano Tamayo L; Silva Cabrera E
Rev Cubana Med Trop; 2007; 59(2):134-8. PubMed ID: 23427447
[TBL] [Abstract][Full Text] [Related]
13. Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs.
Parisi MR; Soldini L; Di Perri G; Tiberi S; Lazzarin A; Lillo FB
New Microbiol; 2009 Oct; 32(4):391-6. PubMed ID: 20128446
[TBL] [Abstract][Full Text] [Related]
14. Adolescent preferences for human immunodeficiency virus testing methods and impact of rapid tests on receipt of results.
Kowalczyk Mullins TL; Braverman PK; Dorn LD; Kollar LM; Kahn JA
J Adolesc Health; 2010 Feb; 46(2):162-8. PubMed ID: 20113922
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the performance of OraQuick ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK.
Zelin J; Garrett N; Saunders J; Warburton F; Anderson J; Moir K; Symonds M; Estcourt C;
Int J STD AIDS; 2008 Oct; 19(10):665-7. PubMed ID: 18824617
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
[TBL] [Abstract][Full Text] [Related]
17. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
[TBL] [Abstract][Full Text] [Related]
18. [Could saliva be used to detect HIV seroconversion?].
Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C
Sante; 1997; 7(5):303-7. PubMed ID: 9480036
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a rapid human immunodeficiency virus test at two community clinics in Kwazulu-Natal.
Phili R; Vardas E
S Afr Med J; 2002 Oct; 92(10):818-21. PubMed ID: 12432808
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.
Torian LV; Forgione LA; Punsalang AE; Pirillo RE; Oleszko WR
J Clin Virol; 2011 Dec; 52 Suppl 1():S41-4. PubMed ID: 21995935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
